Aktie GTAB B GLYCOREX TRANSPLANTATION AB
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Glycorex Transplantation AB

Aktien

GTAB B

SE0000524530

GTAB B

Schlusskurs NORDIC GROWTH MARKET
Andere Börsenplätze
 00:00:00 26.04.2024 		% 5 Tage % 1. Jan.
0.912 SEK -14.77% Intraday Chart für Glycorex Transplantation AB -0.87% -31.17%
28.02. Glycorex Transplantation AB (publ) berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
28.02. Glycorex Transplantation AB (publ) meldet Ergebniszahlen für das vierte Quartal zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Glycorex Transplantation AB Reports Earnings Results for the Full Year Ended December 31, 2023
Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Glycorex Transplantation (GTAB B): Signs agreement with distributor in Romania
Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.
Glycorex Transplantation AB (publ): Interim Report January - September 2023
Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Glycorex Transplantation AB (publ): Interim Report January - June 2023
Glycorex Transplantation AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Glycorex Transplantation AB (publ): Interim Report January - March 2023
Glycorex Transplantation AB Reports Earnings Results for the First Quarter Ended March 31, 2023
Annual Report 2022 Glycorex Transplantation AB (publ)
Published study from the US shows promising results on the use of Glycosorb® ABO to provide low-titer group O whole blood
Glycorex Transplantation AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
The first blood group incompatible kidney transplant using Glycosorb® ABO performed in South Africa
Glycorex strengthens the organization to place additional force behind the growth strategy Going 4 Growth
Glycorex Transplantation AB (GTAB B): Interim report January - September 2022
Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Glycorex Transplantation (GTAB B): Glycosorb[®] ABO used at the largest heart transplant center in Germany
Glycorex Transplantation AB (GTAB B): Interim report January-June 2022
Glycorex Transplantation AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. GTAB B Aktie
  4. Nachrichten Glycorex Transplantation AB
  5. Andere Sprachen